Align Technology, Inc.(ALGN)Earnings, Financials & Key Ratios

ALGN•NASDAQ

$173.94

$12.46B mkt cap·30.8× P/E·Price updated May 6, 2026

SectorHealthcare IndustryMedical Devices Sub-IndustryVision, dental, and ENT devices

AboutAlign Technology, Inc., a medical device company, designs, manufactures, and markets Invisalign clear aligners and iTero intraoral scanners and services for orthodontists and general practitioner dentists, and restorative and aesthetic dentistry. It operates in two segments, Clear Aligner; and Scanners and Services. The Clear Aligner segment consists of comprehensive products, including Invisalign comprehensive treatment that addresses the orthodontic needs of teenage patients, such as mandibular advancement, compliance indicators, and compensation for tooth eruption; and Invisalign First Phase I and Invisalign First Comprehensive Phase 2 package for younger patients generally between the ages of seven and ten years, which is a mixture of primary/baby and permanent teeth. This segment's non-comprehensive products comprise Invisalign moderate, lite and express packages, and Invisalign go; and non-case products include retention products, Invisalign training fees, and sales of ancillary products, such as cleaning material, and adjusting tools used by dental professionals during the course of treatment. The Scanners and Services segment offers iTero scanner, a single hardware platform with software options for restorative or orthodontic procedures; restorative software for general practitioner dentists, prosthodontists, periodontists, and oral surgeons; and software for orthodontists for digital records storage, orthodontic diagnosis, and for the fabrication of printed models and retainers. This segment also provides computer-aided design and computer-aided manufacturing services; ancillary products, such as disposable sleeves for the wand; iTero model and dies; third party scanners and digital scans; Invisalign outcome simulator, a chair-side and cloud-based application for the iTero scanner; Invisalign progress assessment tool; and TimeLapse technology, which allows doctors or practitioners to compare a patient's historic 3D scans to the present-day scan. The company sells its products in the United States, Switzerland, China, and internationally. Align Technology, Inc. was incorporated in 1997 and is headquartered in Tempe, Arizona.Show more

Revenue$4.03B+0.9%
EBITDA$797M+5.9%
Net Income$410M-2.6%
EPS (Diluted)5.65+0.5%
Gross Margin68.33%-2.4%
EBITDA Margin19.75%+4.9%
Operating Margin15.27%+0.5%
Net Margin10.17%-3.5%
ROE10.39%-7.8%
ROIC15.37%-3.1%
Debt/Equity0.03-8.7%

Analysis→Technical→

ALGN Key Insights

Align Technology, Inc. (ALGN) fundamental analysis — strengths, weaknesses & financial health based on data analysis

✓Strengths

✓Company is almost debt free
✓Strong Piotroski F-Score: 7/9
✓High quality earnings: Operating CF exceeds net income
✓Strong 5Y sales CAGR of 10.3%
✓Share count reduced 3.2% through buybacks
✓Healthy 5Y average net margin of 12.3%

✗Weaknesses

✗Profits declining 25.4% over 5 years

* These insights are generated automatically based on available financial data. Please conduct your own research before making investment decisions.

ALGN Price & Volume

Align Technology, Inc. (ALGN) stock price & volume — 10-year historical chart

Loading chart...

ALGN Growth Metrics

Align Technology, Inc. (ALGN) revenue, earnings & EPS growth — 3, 5 & 10-year CAGR

Revenue CAGR

10 Years16.92%

5 Years10.3%

3 Years2.61%

TTM2.89%

Profit CAGR

10 Years11.04%

5 Years-25.4%

3 Years4.31%

TTM4.96%

EPS CAGR

10 Years12.31%

5 Years-24.09%

3 Years7.02%

TTM8.56%

Return on Capital

10 Years23.18%

5 Years17.46%

3 Years15.12%

Last Year14.52%

ALGN Recent Earnings

Align Technology, Inc. (ALGN) EPS & revenue vs analyst estimates — last 4 quarters

Full history →

●Beat EPS 10/12 qtrs (83%)●Beat Revenue 7/12 qtrs (58%)

Q2 2026Latest

Apr 29, 2026

EPS

$2.58

Est $2.26

+14.2%

Revenue

$1.0B

Est $1.0B

+1.8%

Q1 2026

Feb 4, 2026

EPS

$3.29

Est $2.99

+10.0%

Revenue

$1.0B

Est $1.0B

+1.4%

Q4 2025

Oct 29, 2025

EPS

$2.61

Est $2.40

+8.8%

Revenue

$996M

Est $976M

+2.0%

Q3 2025

Jul 30, 2025

EPS

$2.49

Est $2.57

-3.1%

Revenue

$1.0B

Est $1.0B

-0.9%

Quarter	Date	EPS (Act vs Est)	Revenue (Act vs Est)
Q2 2026Latest	Apr 29, 2026	$2.58vs $2.26+14.2%	$1.0Bvs $1.0B+1.8%
Q1 2026	Feb 4, 2026	$3.29vs $2.99+10.0%	$1.0Bvs $1.0B+1.4%
Q4 2025	Oct 29, 2025	$2.61vs $2.40+8.8%	$996Mvs $976M+2.0%
Q3 2025	Jul 30, 2025	$2.49vs $2.57-3.1%	$1.0Bvs $1.0B-0.9%

Based on last 12 quarters of dataView full earnings history →

Company	Market Cap	Stock Price	P/E Ratio (TTM)	Revenue Growth 1Y	Net Margin	Return on Equity (ROE)	FCF Yield	Debt / Equity
XRAYDENTSPLY SIRONA Inc.Direct Competitor	2.23B	11.14	-3.71	-2.98%	-17.06%	-41.19%	4.66%	1.84
HSICHenry Schein, Inc.Direct Competitor	8.31B	72.44	22.15	4.03%	3.02%	8.24%	6.89%	0.77
NVSTEnvista Holdings CorpDirect Competitor	4.46B	27.06	96.64	8.32%	0.58%	0.5%	5.16%	0.51
IDXXIDEXX Laboratories, Inc.Product Competitor	46.12B	579.23	44.28	10.42%	24.63%	70.87%	2.28%	0.67
HOLXHologic, Inc.Product Competitor	16.97B	76.01	30.53	1.74%	13.18%	10.37%	5.42%	0.52
ISRGIntuitive Surgical, Inc.Product Competitor	160.44B	451.73	57.40	20.51%	28.15%	16.89%	1.55%	0.02
GKOSGlaukos CorporationProduct Competitor	7.92B	135.27	-41.24	32.33%	-34.34%	-26.46%		0.21
TMDXTransMedics Group, Inc.Product Competitor	2.52B	72.92	14.97	37.13%	27.04%	41.92%	5.3%	0.99

Compare ALGN vs Peers

Align Technology, Inc. (ALGN) vs competitors — business, growth, and fundamentals comparison against the closest industry rivals.

Closest Rival

vs XRAY

Most directly comparable listed peer for ALGN.

Scale Benchmark

vs ISRG

Larger-name benchmark to compare ALGN against a more recognizable public peer.

Peer Set

Compare Top 5

vs XRAY, HSIC, NVST, IDXX

ALGN Income Statement

Align Technology, Inc. (ALGN) annual income statement — 10-year revenue, gross profit & net income history

10Y historyFree accessUpdated daily

Line item	Dec'17	Dec'18	Dec'19	Dec'20	Dec'21	Dec'22	Dec'23	Dec'24	Dec'25	TTM
Sales/Revenue	1.47B	1.97B	2.41B	2.47B	3.95B	3.73B	3.86B	4B	4.03B	4.1B
Revenue Growth %	36.44%	33.47%	22.39%	2.71%	59.9%	-5.51%	3.42%	3.54%	0.9%	2.89%
Cost of Goods Sold	356.47M	518.63M	662.9M	708.71M	1.02B	1.1B	1.16B	1.2B	1.28B	1.32B
COGS % of Revenue	24.19%	26.37%	27.54%	28.67%	25.74%	29.48%	29.92%	30%	31.67%	-
Gross Profit	1.12B▲ 0%	1.45B▲ 29.6%	1.74B▲ 20.4%	1.76B▲ 1.1%	2.94B▲ 66.5%	2.63B▼ 10.3%	2.71B▲ 2.8%	2.8B▲ 3.4%	2.76B▼ 1.5%	2.77B▲ 0%
Gross Margin %	75.81%	73.63%	72.46%	71.33%	74.26%	70.52%	70.08%	70%	68.33%	67.68%
Gross Profit Growth %	37%	29.63%	20.45%	1.11%	66.48%	-10.27%	2.77%	3.41%	-1.51%	-
Operating Expenses	763.34M	981.3M	1.2B	1.38B	1.96B	1.99B	2.06B	2.19B	2.14B	2.18B
OpEx % of Revenue	51.81%	49.9%	49.92%	55.67%	49.56%	53.32%	53.43%	54.8%	53.05%	-
Selling, General & Admin	665.78M	852.4M	1.07B	1.2B	1.71B	1.67B	1.7B	1.76B	1.76B	1.77B
SG&A % of Revenue	45.19%	43.35%	44.54%	48.58%	43.23%	44.84%	44.1%	44.09%	43.51%	-
Research & Development	97.56M	128.9M	157.36M	175.31M	250.31M	305.26M	346.83M	364.2M	369.91M	371.37M
R&D % of Revenue	6.62%	6.55%	6.54%	7.09%	6.33%	8.17%	8.98%	9.11%	9.17%	-
Other Operating Expenses	0	0	-28.01M	0	0	11.45M	13.32M	64.14M	14.98M	2M
Operating Income	353.61M▲ 0%	466.56M▲ 31.9%	542.49M▲ 16.3%	387.17M▼ 28.6%	976.4M▲ 152.2%	642.6M▼ 34.2%	643.34M▲ 0.1%	607.63M▼ 5.6%	616.22M▲ 1.4%	591.59M▲ 0%
Operating Margin %	24%	23.73%	22.54%	15.66%	24.7%	17.21%	16.66%	15.19%	15.27%	14.44%
Operating Income Growth %	42.06%	31.94%	16.27%	-28.63%	152.19%	-34.19%	0.12%	-5.55%	1.41%	-
EBITDA	391.35M	521.29M	621.48M	480.71M	1.09B	768.39M	785.74M	752.66M	796.8M	789.86M
EBITDA Margin %	26.56%	26.51%	25.82%	19.45%	27.45%	20.57%	20.34%	18.82%	19.75%	19.28%
EBITDA Growth %	43.39%	33.2%	19.22%	-22.65%	125.74%	-29.19%	2.26%	-4.21%	5.86%	7.34%
D&A (Non-Cash Add-back)	37.74M	54.73M	78.99M	93.54M	108.73M	125.79M	142.4M	145.03M	180.59M	198.27M
EBIT	353.61M	466.56M	514.48M	387.17M	976.4M	654.05M	656.65M	671.76M	585.29M	608.59M
Net Interest Income	6.95M	8.58M	12.48M	3.13M	3.1M	5.37M	17.26M	20.22M	16.05M	13.08M
Interest Income	6.95M	8.58M	12.48M	3.13M	3.1M	5.37M	17.26M	20.22M	16.05M	14.64M
Interest Expense	0	0	0	0	0	0	0	0	0	1.56M
Other Income/Expense	11.19M	-8.61M	12.63M	-8.22M	36.02M	-43.54M	-2.13M	1.33M	-30.93M	2.14M
Pretax Income	364.8M▲ 0%	457.96M▲ 25.5%	555.12M▲ 21.2%	378.95M▼ 31.7%	1.01B▲ 167.2%	599.06M▼ 40.8%	641.2M▲ 7.0%	608.96M▼ 5.0%	585.29M▼ 3.9%	593.73M▲ 0%
Pretax Margin %	24.76%	23.29%	23.06%	15.33%	25.61%	16.04%	16.6%	15.23%	14.51%	14.5%
Income Tax	130.16M	57.72M	112.35M	-1.4B	240.4M	237.48M	196.15M	187.6M	174.94M	163.84M
Effective Tax Rate %	35.68%	12.6%	20.24%	-368.64%	23.75%	39.64%	30.59%	30.81%	29.89%	27.59%
Net Income	231.42M▲ 0%	400.24M▲ 72.9%	442.78M▲ 10.6%	1.78B▲ 301.1%	772.02M▼ 56.5%	361.57M▼ 53.2%	445.05M▲ 23.1%	421.36M▼ 5.3%	410.35M▼ 2.6%	429.89M▲ 0%
Net Margin %	15.71%	20.35%	18.4%	71.84%	19.53%	9.68%	11.52%	10.54%	10.17%	10.5%
Net Income Growth %	22%	72.95%	10.63%	301.08%	-56.53%	-53.17%	23.09%	-5.32%	-2.61%	4.96%
Net Income (Continuing)	231.42M	400.24M	442.78M	1.78B	772.02M	361.57M	445.05M	421.36M	410.35M	429.89M
Discontinued Operations	0	0	0	0	0	0	0	0	0	0
Minority Interest	0	0	0	0	0	0	0	0	0	0
EPS (Diluted)	2.83▲ 0%	4.92▲ 73.9%	5.53▲ 12.4%	22.41▲ 305.2%	9.69▼ 56.8%	4.61▼ 52.4%	5.81▲ 26.0%	5.62▼ 3.3%	5.65▲ 0.5%	6.00▲ 0%
EPS Growth %	21.46%	73.85%	12.4%	305.24%	-56.76%	-52.43%	26.03%	-3.27%	0.53%	8.56%
EPS (Basic)	2.89	5.00	5.57	22.55	9.78	4.62	5.82	5.63	5.66	-
Diluted Shares Outstanding	81.83M	81.36M	80.1M	79.23M	79.67M	78.42M	76.57M	74.99M	72.59M	71.61M
Basic Shares Outstanding	80.08M	80.06M	79.42M	78.76M	78.92M	78.19M	76.43M	74.88M	72.54M	71.42M
Dividend Payout Ratio	-	-	-	-	-	-	-	-	-	-

ALGN Balance Sheet

Align Technology, Inc. (ALGN) balance sheet — assets, liabilities & shareholders' equity

Line item	Dec'17	Dec'18	Dec'19	Dec'20	Dec'21	Dec'22	Dec'23	Dec'24	Dec'25	TTM
Total Current Assets	1.16B	1.3B	1.63B	1.85B	2.49B	2.42B	2.45B	2.49B	2.62B	2.66B
Cash & Short-Term Investments	721.54M	735.36M	868.63M	960.84M	1.17B	999.58M	972.74M	1.04B	1.09B	1.06B
Cash Only	449.51M	636.9M	550.42M	960.84M	1.1B	942.05M	937.44M	1.04B	1.08B	1.06B
Short-Term Investments	272.03M	98.46M	318.2M	0	71.97M	57.53M	35.3M	0	15.92M	0
Accounts Receivable	324.19M	482.31M	616.55M	657.7M	990.81M	1B	1.05B	1.03B	1.16B	1.13B
Days Sales Outstanding	80.31	89.52	93.5	97.11	91.5	97.75	98.96	93.98	104.71	101.95
Inventory	31.69M	55.64M	112.05M	139.24M	230.23M	338.75M	296.9M	254.29M	226.34M	214.94M
Days Inventory Outstanding	32.45	39.16	61.7	71.71	82.61	112.32	93.79	77.36	64.64	62.95
Other Current Assets	0	0	24.42M	61.69M	31.48M	16.76M	77.33M	81.58M	75.26M	255.54M
Total Non-Current Assets	620.85M	749.98M	867.28M	2.98B	3.45B	3.52B	3.64B	3.72B	3.62B	3.66B
Property, Plant & Equipment	348.79M	521.33M	687.97M	817.27M	1.2B	1.35B	1.41B	1.38B	1.24B	1.22B
Fixed Asset Turnover	4.22x	3.77x	3.50x	3.02x	3.29x	2.76x	2.74x	2.89x	3.25x	3.19x
Goodwill	64.61M	64.03M	63.92M	444.82M	418.55M	407.55M	419.53M	442.63M	491.83M	503.04M
Intangible Assets	24.45M	17.92M	11.77M	130.07M	109.71M	95.72M	82.12M	103.49M	93.93M	100.82M
Long-Term Investments	94.55M	64.89M	5.89M	0	125.32M	41.98M	8.02M	0	0	0
Other Non-Current Assets	38.38M	17.13M	33.72M	35.15M	57.51M	55.83M	128.68M	234.16M	278.05M	1.15B
Total Assets	1.78B▲ 0%	2.05B▲ 15.4%	2.5B▲ 21.8%	4.83B▲ 93.1%	5.94B▲ 23.0%	5.95B▲ 0.1%	6.08B▲ 2.3%	6.21B▲ 2.1%	6.23B▲ 0.3%	6.31B▲ 0%
Asset Turnover	0.83x	0.96x	0.96x	0.51x	0.67x	0.63x	0.63x	0.64x	0.65x	0.66x
Asset Growth %	27.34%	15.45%	21.84%	93.13%	23.03%	0.1%	2.29%	2.15%	0.31%	2.68%
Total Current Liabilities	497.82M	692.07M	970.97M	1.33B	1.92B	1.93B	2.07B	2.04B	1.92B	1.91B
Accounts Payable	36.78M	64.26M	87.25M	142.13M	163.89M	127.87M	113.13M	108.69M	121.45M	123.72M
Days Payables Outstanding	37.66	45.22	48.04	73.2	58.81	42.4	35.74	33.06	34.68	33.44
Short-Term Debt	0	0	0	0	0	0	0	0	31.94M	0
Deferred Revenue (Current)	273.09M	393.14M	563.76M	777.89M	1.15B	1.34B	1.43B	1.33B	1.26B	5.11B
Other Current Liabilities	5.06M	101.82M	127.61M	183.61M	262.4M	203.97M	237.16M	0	234.61M	546.88M
Current Ratio	2.32x	1.88x	1.68x	1.40x	1.30x	1.26x	1.18x	1.22x	1.36x	1.36x
Quick Ratio	2.26x	1.80x	1.57x	1.29x	1.18x	1.08x	1.04x	1.10x	1.24x	1.24x
Cash Conversion Cycle	75.1	83.46	107.16	95.62	115.3	167.67	157.02	138.27	134.67	131.46
Total Non-Current Liabilities	129.67M	107.49M	183.56M	270.22M	395.32M	420.7M	386.78M	324.59M	264.53M	258.9M
Long-Term Debt	0	0	0	0	0	0	0	0	0	0
Capital Lease Obligations	0	0	43.46M	64.44M	102.66M	100.33M	96.97M	88.21M	82.51M	343.68M
Deferred Tax Liabilities	0	0	0	0	0	0	0	0	0	0
Other Non-Current Liabilities	129.67M	107.49M	140.1M	205.77M	292.67M	320.37M	289.81M	236.37M	182.02M	800.21M
Total Liabilities	627.49M	799.57M	1.15B	1.6B	2.32B	2.35B	2.45B	2.36B	2.18B	2.16B
Total Debt	0	0	59.2M	86.18M	125.38M	126.91M	126.62M	119.28M	114.45M	83.42M
Net Debt	-449.51M	-636.9M	-491.23M	-874.66M	-974M	-815.14M	-810.82M	-924.61M	-964.54M	-976.41M
Debt / Equity	-	-	0.04x	0.03x	0.03x	0.04x	0.03x	0.03x	0.03x	0.03x
Debt / EBITDA	-	-	0.10x	0.18x	0.12x	0.17x	0.16x	0.16x	0.14x	0.11x
Net Debt / EBITDA	-1.15x	-1.22x	-0.79x	-1.82x	-0.90x	-1.06x	-1.03x	-1.23x	-1.21x	-1.21x
Interest Coverage	-	-	-	-	-	-	-	-	-	389.13x
Total Equity	1.15B▲ 0%	1.25B▲ 8.9%	1.35B▲ 7.4%	3.23B▲ 140.2%	3.62B▲ 12.0%	3.6B▼ 0.6%	3.63B▲ 0.8%	3.85B▲ 6.1%	4.05B▲ 5.1%	4.15B▲ 0%
Equity Growth %	15.57%	8.91%	7.45%	140.23%	12.02%	-0.59%	0.81%	6.1%	5.12%	18.93%
Book Value per Share	14.06	15.40	16.81	40.82	45.47	45.92	47.42	51.36	55.78	57.94
Total Shareholders' Equity	1.15B	1.25B	1.35B	3.23B	3.62B	3.6B	3.63B	3.85B	4.05B	4.15B
Common Stock	8K	8K	8K	8K	8K	8K	7K	7K	7K	0
Retained Earnings	263.36M	378.14M	439.91M	2.22B	2.62B	2.57B	2.45B	2.48B	2.46B	0
Treasury Stock	0	0	0	0	0	0	0	0	0	0
Accumulated OCI	571K	-2.77M	-688K	43.5M	4.33M	-10.28M	21.17M	5.98M	75.39M	0
Minority Interest	0	0	0	0	0	0	0	0	0	0

ALGN Cash Flow Statement

Align Technology, Inc. (ALGN) cash flow — operating, investing & free cash flow history

Line item	Dec'17	Dec'18	Dec'19	Dec'20	Dec'21	Dec'22	Dec'23	Dec'24	Dec'25	TTM
Cash from Operations	438.54M	554.68M	747.27M	662.17M	1.17B	568.73M	785.78M	738.23M	593.22M	593.22M
Operating CF Margin %	29.76%	28.21%	31.05%	26.79%	29.67%	15.23%	20.34%	18.46%	14.7%	-
Operating CF Growth %	77.08%	26.48%	34.72%	-11.39%	77.07%	-51.5%	38.16%	-6.05%	-19.64%	116.82%
Net Income	231.42M	400.24M	442.78M	1.78B	772.02M	361.57M	445.05M	421.36M	410.35M	429.89M
Depreciation & Amortization	37.74M	54.73M	78.99M	93.54M	108.73M	125.79M	142.4M	145.03M	237.44M	118.55M
Stock-Based Compensation	58.85M	70.76M	88.18M	98.43M	114.34M	133.37M	154.03M	173.7M	0	140.87M
Deferred Taxes	17.57M	-15.68M	307K	-1.49B	15.46M	-39.49M	-18.64M	25.76M	33.09M	161K
Other Non-Cash Items	17.07M	25.95M	61.8M	56.21M	7.77M	71.81M	70.83M	44.81M	268.37M	404.47M
Working Capital Changes	75.89M	18.69M	75.21M	129.69M	154.24M	-84.31M	-7.89M	-72.43M	-356.01M	-185.23M
Change in Receivables	-90.99M	-109.22M	-121.01M	-139.78M	-262.07M	21.55M	-104.61M	-153.49M	-139.91M	-74.61M
Change in Inventory	-5.48M	-24.11M	-58.27M	-29.11M	-112.45M	-130.1M	30.17M	25.05M	808K	-6.59M
Change in Payables	8.18M	25.05M	22.1M	52.21M	19.75M	-36.52M	-7.7M	-843K	5.33M	-3.25M
Cash from Investing	-248.31M	6.93M	-350.44M	-231.51M	-563.43M	-213.32M	-195.94M	-254.91M	-112.44M	-218.74M
Capital Expenditures	-195.69M	-223.31M	-149.71M	-154.92M	-401.1M	-291.9M	-177.72M	-115.58M	-102.44M	72.06M
CapEx % of Revenue	13.28%	11.36%	6.22%	6.27%	10.15%	7.82%	4.6%	2.89%	2.54%	-
Acquisitions	-21.72M	-5M	0	-420.79M	-8M	-12.3M	-77M	-183.42M	0	0
Investments	-	-	-	-	-	-	-	-	-	-
Other Investing	-29.43M	30.77M	7.12M	28.08M	-417K	-2.21M	278K	235K	0	-290.79M
Cash from Financing	-135.5M	-369.43M	-485.54M	-30.81M	-458.33M	-501.69M	-598.34M	-355.72M	-464.58M	-305.95M
Debt Issued (Net)	0	0	-45.77M	0	0	0	0	0	0	0
Equity Issued (Net)	-89.33M	-283.37M	-382.09M	20.31M	-349.42M	-408.89M	-565.76M	-327.6M	-444.19M	-181.51M
Dividends Paid	0	0	0	0	0	0	0	0	0	0
Share Repurchases	-103.79M	-300M	-400M	0	-375.04M	-435.04M	-592.36M	-352.88M	-465.94M	-189.35M
Other Financing	-46.17M	-86.07M	-57.67M	-51.12M	-108.92M	-92.8M	-32.58M	-28.13M	-20.39M	-124.44M
Net Change in Cash	60.24M▲ 0%	187.44M▲ 211.2%	-86.43M▼ 146.1%	410.34M▲ 574.8%	138.66M▼ 66.2%	-157.78M▼ 213.8%	-3.84M▲ 97.6%	106.44M▲ 2874.9%	51.22M▼ 51.9%	187.06M▲ 0%
Free Cash Flow	242.84M▲ 0%	331.37M▲ 36.5%	597.56M▲ 80.3%	507.26M▼ 15.1%	771.45M▲ 52.1%	276.83M▼ 64.1%	608.06M▲ 119.6%	622.65M▲ 2.4%	490.78M▼ 21.2%	716.88M▲ 0%
FCF Margin %	16.48%	16.85%	24.83%	20.52%	19.52%	7.41%	15.74%	15.57%	12.16%	17.5%
FCF Growth %	37.14%	36.45%	80.33%	-15.11%	52.08%	-64.12%	119.65%	2.4%	-21.18%	13.66%
FCF per Share	2.97	4.07	7.46	6.40	9.68	3.53	7.94	8.30	6.76	6.76
FCF Conversion (FCF/Net Income)	1.90x	1.39x	1.69x	0.37x	1.52x	1.57x	1.77x	1.75x	1.45x	1.67x
Interest Paid	0	0	0	0	0	0	0	0	0	0
Taxes Paid	51.23M	0	0	76.33M	203.31M	231.88M	294.57M	177.08M	0	0

ALGN Key Ratios

Align Technology, Inc. (ALGN) financial ratios — P/E, ROE, debt and 30+ core market and balance-sheet ratios

Metric	2017	2018	2019	2020	2021	2022	2023	2024	2025	TTM
Return on Equity (ROE)	21.57%	33.31%	34.07%	77.55%	22.52%	10.01%	12.31%	11.26%	10.39%	10.7%
Return on Invested Capital (ROIC)	40.58%	53.15%	55.32%	18.07%	29.25%	17.74%	17.21%	15.86%	15.37%	15.37%
Gross Margin	75.81%	73.63%	72.46%	71.33%	74.26%	70.52%	70.08%	70%	68.33%	67.68%
Net Margin	15.71%	20.35%	18.4%	71.84%	19.53%	9.68%	11.52%	10.54%	10.17%	10.5%
Debt / Equity	-	-	0.04x	0.03x	0.03x	0.04x	0.03x	0.03x	0.03x	0.03x
Interest Coverage	-	-	-	-	-	-	-	-	-	389.13x
FCF Conversion	1.90x	1.39x	1.69x	0.37x	1.52x	1.57x	1.77x	1.75x	1.45x	1.67x
Revenue Growth	36.44%	33.47%	22.39%	2.71%	59.9%	-5.51%	3.42%	3.54%	0.9%	2.89%

ALGN SEC Filings & Documents

Align Technology, Inc. (ALGN) SEC filings — annual & quarterly reports (10-K, 10-Q)

8-K Announcements

Material company update

Apr 29, 2026·SEC

Material company update

Feb 26, 2026·SEC

Material company update

Feb 4, 2026·SEC

10-K Annual Reports

FY 2026

Feb 27, 2026·SEC

FY 2025

Feb 28, 2025·SEC

FY 2024

Feb 28, 2024·SEC

10-Q Quarterly Reports

FY 2025

Nov 5, 2025·SEC

FY 2025

Aug 6, 2025·SEC

FY 2025

May 8, 2025·SEC

ALGN Frequently Asked Questions

Align Technology, Inc. (ALGN) stock FAQ — growth, dividends, profitability & financials explained

Growth & Financials

Align Technology, Inc. (ALGN) reported $4.10B in revenue for fiscal year 2025. This represents a 996442% increase from $0.4M in 1999.

Align Technology, Inc. (ALGN) grew revenue by 0.9% over the past year. Growth has been modest.

Yes, Align Technology, Inc. (ALGN) is profitable, generating $429.9M in net income for fiscal year 2025 (10.2% net margin).

Dividend & Returns

Align Technology, Inc. (ALGN) has a return on equity (ROE) of 10.4%. This is reasonable for most industries.

Align Technology, Inc. (ALGN) generated $716.9M in free cash flow for fiscal year 2025. Positive FCF indicates the company can fund dividends, buybacks, or reinvestment.

Explore More ALGN

Align Technology, Inc. (ALGN) financial analysis — history, returns, DCA and operating performance tools

Full ALGN Stock Analysis

Analyst verdict, bull/bear case, risk factors and peer comparison

→

Total Return Calculator

Historical returns with dividends reinvested

→

DCA Calculator

Dollar cost averaging vs lump sum

→

Dividend History

Yield, growth, payout safety & DRIP

→

Earnings History

EPS trends, net income & profitability

→

Price History

Long-term charts & historical price data

→

Revenue History

Sales growth patterns & revenue breakdown

→

Financial Ratios

30 years of market, efficiency and balance-sheet ratios

→

Valuation

DCF intrinsic value, peer multiples & estimates

→

Align Technology, Inc.(ALGN)Earnings, Financials & Key Ratios

ALGN Key Insights

✓Strengths

✗Weaknesses

ALGN Price & Volume

ALGN Growth Metrics

Revenue CAGR

Profit CAGR

EPS CAGR

Return on Capital

ALGN Recent Earnings

ALGN Peer Comparison

Compare ALGN vs Peers

vs XRAY

vs ISRG

Compare Top 5

ALGN Income Statement

ALGN Balance Sheet

ALGN Cash Flow Statement

ALGN Key Ratios

ALGN SEC Filings & Documents

8-K Announcements

10-K Annual Reports

10-Q Quarterly Reports

ALGN Frequently Asked Questions

Explore More ALGN

Full ALGN Stock Analysis

Total Return Calculator

DCA Calculator

Dividend History

Earnings History

Price History

Revenue History

Financial Ratios

Valuation